Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients

Exclusion Criteria

• •Hypersensitivity to any vaccine component Active infections including but not limited to human immunodeficiency virus (HIV positive), Hepatitis B or C, tuberculosis.
• •Positive purified protein derivative (PPD) test results without evidence of prior treatment or administration of bacilli Calmette-Guerin (BCG) vaccine. A positive PPD is defined as ≥ 5 mm induration 24-38 hours after receiving 5TU (TU=tuberculin units) of PPD.
• •Pregnancy or desire to become pregnant during the study period. Breast feeding. Inability to complete the immunization series. Received any blood product or component in the previous 6 months before enrollment.
• •Received any inactivated vaccine product within 14 days before enrollment. Received any live vaccine product within 21 days before enrollment.
• •Fever (temperature \> 100°F) at the time of enrollment. Inability to provided informed consent.